Faculty of Pharmacy, Middle East University, Amman, 11831, Jordan.
Department of Pharmacy, Al-Noor University College, Nineveh, Iraq.
Curr Microbiol. 2024 Nov 30;82(1):25. doi: 10.1007/s00284-024-04004-0.
The human gut microbiome is a dynamic and intricate ecosystem, composed of trillions of microorganisms that play a pivotal role in maintaining overall health and well-being. However, the gut microbiome is constantly exposed to various environmental factors, including the bile produced by the liver, which can significantly impact its composition and function. Bile acids, secreted by the liver and stored in the gallbladder, modulate the gut microbiome, influencing its composition and function. This altered microbiome profile can, in turn, impact the tumor microenvironment (TME), promoting an immunosuppressive environment that favors tumor growth and metastasis. Furthermore, changes in the gut microbiome can also influence the production of bile acids and other metabolites that directly affect cancer cells and their behavior. Moreover, bile acids have been shown to shape the microbiome and increase antibiotic resistance, underscoring the need for targeted interventions. This review provides a comprehensive overview of the intricate relationships between bile, the gut microbiome, and the TME, highlighting the mechanisms by which this interplay drives cancer progression and resistance to therapy. Understanding these complex interactions is crucial for developing novel therapeutic strategies that target the gut-bile-TME axis and improve patient outcomes.
人类肠道微生物群是一个动态而复杂的生态系统,由数万亿种微生物组成,这些微生物在维持整体健康和福祉方面起着关键作用。然而,肠道微生物群不断受到各种环境因素的影响,包括肝脏产生的胆汁,这会显著影响其组成和功能。胆汁酸由肝脏分泌并储存在胆囊中,调节肠道微生物群,影响其组成和功能。这种改变的微生物群谱反过来又会影响肿瘤微环境 (TME),促进有利于肿瘤生长和转移的免疫抑制环境。此外,肠道微生物群的变化也会影响胆汁酸和其他代谢物的产生,这些代谢物直接影响癌细胞及其行为。此外,胆汁酸已被证明可以塑造微生物群并增加抗生素耐药性,这突显了靶向干预的必要性。这篇综述全面概述了胆汁、肠道微生物群和 TME 之间错综复杂的关系,强调了这种相互作用驱动癌症进展和对治疗的耐药性的机制。了解这些复杂的相互作用对于开发靶向肠道-胆汁-TME 轴的新型治疗策略以改善患者预后至关重要。